Added to YB: 2024-07-31
Pitch date: 2024-07-26
NXGL [bullish]
NEXGEL, Inc.
-48.38%
current return
Author Info
Ahead of the Curve focuses on identifying and owning great small cap companies. Sign up for the newsletter.
Company Info
NEXGEL, Inc. manufactures and sells high water content, electron beam cross-linked, and aqueous polymer hydrogels and gels for wound care, medical diagnostics, transdermal drug delivery, and cosmetics in the United States.
Market Cap
$12.2M
Pitch Price
$3.08
Price Target
5.50 (+229%)
Dividend
N/A
EV/EBITDA
-6.74
P/E
-3.97
EV/Sales
1.27
Sector
Health Care Equipment and Supplies
Category
growth
Nexgel: Who knew hydrogel could be so exciting?
NXGL: Hydrogel maker, 80% rev growth, monopoly, expanding margins. AbbVie deal could add $10M+ ARR. STADA partnership opens Europe. Medical devices launching 2025. Amazon sales $2.5-3M. Kenkoderm acquisition accretive. 2025 est: $13.7M+ rev, $2.35M+ EBITDA. Trades 8x conservative fwd EBITDA. Risks: tight cash, warrants. High insider ownership.
Read full article (13 min)